Yuki Tsuji
is a Japanese ''ikebana'' artist, a master of the Japanese art of flower arrangement. Provided by Wikipedia
Showing 1 - 20 results of 25 for search 'Yuki Tsuji', query time: 0.08s
Refine Results
-
1
Infants’ Hemodynamic Modulation in the Temporal Region by Yuki Tsuji, So Kanazawa, Masami K. Yamaguchi
Published 2022-03-01
Article -
2
-
3
Importance and difficulty of correctly diagnosing covered cloacal exstrophy for adequate reconstruction: A case report by Insu Kawahara, Shigeru Ono, Katsuhisa Baba, Atsuhisa Fukuta, Yuki Tsuji, Yoshiko Usui, Taiju Hyuga, Shina Kawai, Shigeru Nakamura, Hideo Nakai
Published 2015-02-01
Article -
4
Comparison of Ablation Area and Change in Functional Liver Reserve after Radiofrequency Ablation for Hepatocellular Carcinoma Using the arfa<sup>®</sup> and VIVA<sup>®</sup> System... by Hiroaki Takaya, Tadashi Namisaki, Kazusuke Matsumoto, Junya Suzuki, Koji Murata, Yuki Tsuji, Keisuke Nakanishi, Kosuke Kaji, Mitsuteru Kitade, Ryuichi Noguchi, Hitoshi Yoshiji
Published 2022-01-01
Article -
5
Small intestinal follicular lymphoma induced by methotrexate: a case report by Yui Osaki, Hideto Kawaratani, Hiroki Kachi, Kyohei Matsuura, Yuki Tsuji, Takahiro Ozutsumi, Hirotetsu Takagi, Masanori Furukawa, Yasuhiko Sawada, Akira Mitoro, Junichi Yamao, Hitoshi Yoshiji
Published 2021-07-01
Article -
6
A Combination of an Angiotensin II Receptor and a Neprilysin Inhibitor Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation by Junya Suzuki, Kosuke Kaji, Norihisa Nishimura, Takahiro Kubo, Fumimasa Tomooka, Akihiko Shibamoto, Satoshi Iwai, Yuki Tsuji, Yukihisa Fujinaga, Koh Kitagawa, Tadashi Namisaki, Takemi Akahane, Hitoshi Yoshiji
Published 2023-04-01
Article -
7
The Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity: Usefulness as a Prognostic Biomarker in Acute-on-Chronic Liver Failure by Hiroaki Takaya, Tadashi Namisaki, Masahide Enomoto, Takahiro Kubo, Yuki Tsuji, Yukihisa Fujinaga, Norihisa Nishimura, Kosuke Kaji, Hideto Kawaratani, Kei Moriya, Takemi Akahane, Masanori Matsumoto, Hitoshi Yoshiji
Published 2023-01-01
Article -
8
Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis by Yuki Tsuji, Kosuke Kaji, Mitsuteru Kitade, Daisuke Kaya, Koh Kitagawa, Takahiro Ozutsumi, Yukihisa Fujinaga, Hiroaki Takaya, Hideto Kawaratani, Tadashi Namisaki, Kei Moriya, Takemi Akahane, Hitoshi Yoshiji
Published 2020-06-01
Article -
9
TGR5 Activation Modulates an Inhibitory Effect on Liver Fibrosis Development Mediated by Anagliptin in Diabetic Rats by Daisuke Kaya, Kosuke Kaji, Yuki Tsuji, Satoko Yamashita, Koh Kitagawa, Takahiro Ozutsumi, Yukihisa Fujinaga, Hiroaki Takaya, Hideto Kawaratani, Kei Moriya, Tadashi Namisaki, Takemi Akahane, Hitoshi Yoshiji
Published 2019-09-01
Article -
10
Increased Endotoxin Activity Is Associated with the Risk of Developing Acute-on-Chronic Liver Failure by Hiroaki Takaya, Tadashi Namisaki, Shinya Sato, Kosuke Kaji, Yuki Tsuji, Daisuke Kaya, Yukihisa Fujinaga, Yasuhiko Sawada, Naotaka Shimozato, Hideto Kawaratani, Kei Moriya, Takemi Akahane, Akira Mitoro, Hitoshi Yoshiji
Published 2020-05-01
Article -
11
Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis by Norihisa Nishimura, Kosuke Kaji, Koh Kitagawa, Yasuhiko Sawada, Masanori Furukawa, Takahiro Ozutsumi, Yukihisa Fujinaga, Yuki Tsuji, Hiroaki Takaya, Hideto Kawaratani, Kei Moriya, Tadashi Namisaki, Takemi Akahane, Hiroshi Fukui, Hitoshi Yoshiji
Published 2021-06-01
Article -
12
Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients by Kosuke Kaji, Soichiro Saikawa, Hiroaki Takaya, Yukihisa Fujinaga, Masanori Furukawa, Koh Kitagawa, Takahiro Ozutsumi, Daisuke Kaya, Yuki Tsuji, Yasuhiko Sawada, Hideto Kawaratani, Kei Moriya, Tadashi Namisaki, Takemi Akahane, Akira Mitoro, Hitoshi Yoshiji
Published 2020-03-01
Article -
13
Association between Equol Production Status and Nonalcoholic Steatohepatitis by Takemi Akahane, Daisuke Kaya, Ryuichi Noguchi, Kosuke Kaji, Haruna Miyakawa, Yukihisa Fujinaga, Yuki Tsuji, Hiroaki Takaya, Yasuhiko Sawada, Masanori Furukawa, Koh Kitagawa, Takahiro Ozutsumi, Hideto Kawaratani, Kei Moriya, Tadashi Namisaki, Hitoshi Yoshiji
Published 2021-11-01
Article -
14
VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma by Hiroaki Takaya, Tadashi Namisaki, Mitsuteru Kitade, Kosuke Kaji, Keisuke Nakanishi, Yuki Tsuji, Naotaka Shimozato, Kei Moriya, Kenichiro Seki, Yasuhiko Sawada, Soichiro Saikawa, Shinya Sato, Hideto Kawaratani, Takemi Akahane, Ryuichi Noguchi, Masanori Matsumoto, Hitoshi Yoshiji
Published 2019-10-01
Article -
15
Association between Non-Alcoholic Fatty Liver Disease and Chronic Kidney Disease: A Cross-Sectional Study by Takemi Akahane, Manabu Akahane, Tadashi Namisaki, Kosuke Kaji, Kei Moriya, Hideto Kawaratani, Hiroaki Takaya, Yasuhiko Sawada, Naotaka Shimozato, Yukihisa Fujinaga, Masanori Furukawa, Koh Kitagawa, Takahiro Ozutsumi, Yuki Tsuji, Daisuke Kaya, Akira Mitoro, Hitoshi Yoshiji
Published 2020-05-01
Article -
16
ADAMTS13, VWF, and Endotoxin Are Interrelated and Associated with the Severity of Liver Cirrhosis via Hypercoagulability by Hiroaki Takaya, Tadashi Namisaki, Shohei Asada, Satoshi Iwai, Takahiro Kubo, Junya Suzuki, Masahide Enomoto, Yuki Tsuji, Yukihisa Fujinaga, Norihisa Nishimura, Yasuhiko Sawada, Kosuke Kaji, Hideto Kawaratani, Kei Moriya, Takemi Akahane, Masanori Matsumoto, Hitoshi Yoshiji
Published 2022-03-01
Article -
17
Macrophage Activation Markers Predict Liver-Related Complications in Primary Biliary Cholangitis by Yukihisa Fujinaga, Tadashi Namisaki, Yuki Tsuji, Junya Suzuki, Koji Murata, Soichi Takeda, Hiroaki Takaya, Takashi Inoue, Ryuichi Noguchi, Yuki Fujimoto, Masahide Enomoto, Norihisa Nishimura, Koh Kitagawa, Kosuke Kaji, Hideto Kawaratani, Takemi Akahane, Akira Mitoro, Hitoshi Yoshiji
Published 2022-08-01
Article -
18
Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis by Yukihisa Fujinaga, Hideto Kawaratani, Daisuke Kaya, Yuki Tsuji, Takahiro Ozutsumi, Masanori Furukawa, Koh Kitagawa, Shinya Sato, Norihisa Nishimura, Yasuhiko Sawada, Hiroaki Takaya, Kosuke Kaji, Naotaka Shimozato, Kei Moriya, Tadashi Namisaki, Takemi Akahane, Akira Mitoro, Hitoshi Yoshiji
Published 2020-08-01
Article -
19
The Combination of Albumin–Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child–Pugh Class... by Hiroaki Takaya, Tadashi Namisaki, Soichi Takeda, Kosuke Kaji, Hiroyuki Ogawa, Koji Ishida, Yuki Tsuji, Hirotetsu Takagi, Takahiro Ozutsumi, Yukihisa Fujinaga, Masanori Furukawa, Koh Kitagawa, Norihisa Nishimura, Yasuhiko Sawada, Naotaka Shimozato, Hideto Kawaratani, Kei Moriya, Takemi Akahane, Akira Mitoro, Hitoshi Yoshiji
Published 2021-10-01
Article -
20
Plasma copeptin concentration is a predictor of tolvaptan efficacy in patients with hepatic ascites by Fumimasa Tomooka, Kei Moriya, Takahiro Kubo, Akihiko Shibamoto, Jyunya Suzuki, Satoshi Iwai, Soichi Takeda, Yuki Fujimoto, Masahide Enomoto, Koji Murata, Yuki Tsuji, Yukihisa Fujinaga, Koh Kitagawa, Norihisa Nishimura, Hiroaki Takaya, Kosuke Kaji, Hideto Kawaratani, Tadashi Namisaki, Takemi Akahane, Akira Mitoro, Hitoshi Yoshiji
Published 2023-09-01
Article